|
KOBAYAKAWA Takuya
|
Graduating School 【 display / non-display 】
-
Waseda University, School of Advance Science and Engineering, Department of Applied Chemistry, 2012.03, Graduated
Graduate School 【 display / non-display 】
-
Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Science and Technology Track, Master's Course, 2014.03, Completed
-
Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Life Science and Technology Track, Doctor's Course, 2017.03, Completed
Degree 【 display / non-display 】
-
Doctor (Engineering), Tokyo Medical and Dental University
-
Master (Engineering), Tokyo Medical and Dental University
-
Bachelor (Engineering), Waseda University
Campus Career 【 display / non-display 】
-
2012.04-2014.03Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Science and Technology, Graduate Student
-
2014.04-2017.03Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Life Science and Technology, Life Science and Technology, Medicinal Chemistry, Graduate Student
-
2017.04-2017.09Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biomolecular Chemistry, Medicinal Chemistry, Junior Associate Professor
-
2017.10-2023.03Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Biomolecular Chemistry, Medicinal Chemistry, Assistant Professor
-
2023.04-NowTokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, -, Medicinal Chemistry, Assistant Professor
External Career 【 display / non-display 】
-
2014.04-2016.03Tokyo Medical and Dental University, Institute of Biomaterials and Bioengineering, Research Assistant
-
2015.04-2016.03Tokyo Kasei University,
-
2016.04-2017.03Japan Society for the Promotion of Science, Research Fellowships for Young Scientists, Research Fellowships for Young Scientists
-
2017.04-2017.09Japan Society for the Promotion of Science, Research Fellowships for Young Scientists, Research Fellowships for Young Scientists
Academic Society Affiliations 【 display / non-display 】
-
The Pharmaceutical Society of Japan
-
Japanese Society for Chemical Biology
-
The Society of Synthetic Organic Chemistry, Japan
-
The Japanese Peptide Society
-
American Chemical Society
-
The Chemical Society of Japan
Academic Activity 【 display / non-display 】
-
2013.06The 8th Annual Meeting of Japanese Society for Chemical Biology The 8th Annual Meeting of Japanese Society for Chemical Biology, Cooperation Staff
-
2017.10-NowInstitute of Biomaterials and Bioengineering, Tokyo Medical and Dental University Open Campus Committee
-
2018.06The 13th Annual Meeting of Japanese Society for Chemical Biology The 13th Annual Meeting of Japanese Society for Chemical Biology, Cooperation Staff
Research Areas 【 display / non-display 】
-
Pharmaceutical chemistry and drug development sciences
-
Synthetic organic chemistry
-
Chemical biology
Qualification Acquired 【 display / non-display 】
-
Hazardous Material Handler (first kind)
-
Usual Car License (first kind)
Published Papers & Misc 【 display / non-display 】
-
Kobayakawa T, Tsuji K, Tamamura H. Design, synthesis and evaluation of bioactivity of peptidomimetics based on chloroalkene dipeptide isosteres. Bioorganic & medicinal chemistry. 2024.08; 110 117811. ( PubMed, DOI )
-
Ishii T, Kobayakawa T, Matsuda K, Nigorikawa K, Bolah P, Noborio A, Tsuji K, Ohashi N, Yoshimura K, Nomura W, Mitsuya H, Maeda K, Tamamura H. Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents. ACS infectious diseases. 2024.05; 10 (6): 2250-2261. ( PubMed, DOI )
-
Kobayakawa Takuya, Yokoyama Masaru, Tsuji Kohei, Boku Sayaka, Kurakami Masaki, Fujino Masayuki, Ishii Takahiro, Miura Yutaro, Nishimura Soshi, Shinohara Kouki, Yamamoto Kenichi, Bolah Peter, Kotani Osamu, Murakami Tsutomu, Sato Hironori, Tamamura Hirokazu. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins(タイトル和訳中) Chemical & Pharmaceutical Bulletin. 2024.01; 72 (1): 41-47. ( ichushi )
-
Kobayakawa T, Takano H, Ishii T, Bolah P, Tsuji K, Ohashi N, Nomura W, Furuta T, Tamamura H. Effect of Two-Photon Excitation to 8-Azacoumarin Derivatives as Photolabile Protecting Groups. Chemical & pharmaceutical bulletin. 2024; 72 (3): 311-312. ( PubMed, DOI )
-
Kobayakawa T, Yokoyama M, Tsuji K, Boku S, Kurakami M, Fujino M, Ishii T, Miura Y, Nishimura S, Shinohara K, Yamamoto K, Bolah P, Kotani O, Murakami T, Sato H, Tamamura H. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Chemical & pharmaceutical bulletin. 2024; 72 (1): 41-47. ( PubMed, DOI )
-
Tsuji Kohei, Kobayakawa Takuya, Ishii Takahiro, Higashi-Kuwata Nobuyo, Azuma Chika, Shinohara Kouki, Miura Yutaro, Yamamoto Kenichi, Nishimura Soshi, Hattori Shin-ichiro, Bulut Haydar, Mitsuya Hiroaki, Tamamura Hirokazu. Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement(タイトル和訳中) Chemical & Pharmaceutical Bulletin. 2023.12; 71 (12): 879-886. ( ichushi )
-
Tsuji K, Ishii T, Kobayakawa T, Higashi-Kuwata N, Shinohara K, Azuma C, Miura Y, Nakano H, Wada N, Hattori SI, Bulut H, Mitsuya H, Tamamura H. Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties. Journal of medicinal chemistry. 2023.09; 66 (19): 13516-13529. ( PubMed, DOI )
-
Ishii T, Kobayakawa T, Matsuda K, Tsuji K, Ohashi N, Nakahata S, Noborio A, Yoshimura K, Mitsuya H, Maeda K, Tamamura H. Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity. European journal of medicinal chemistry. 2023.08; 256 115449. ( PubMed, DOI )
-
Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, Takahiro Ishii, Kouki Shinohara, Takuya Kobayakawa, Akino Emi, Takashi Nakano, Youichi Suzuki, Hirokazu Tamamura . Dimerized fusion inhibitor peptides targeting the HR1–HR2 interaction of SARS-CoV-2 RSC Advances. 2023.03; 13 8779-8793.
-
Higashi-Kuwata N, Tsuji K, Hayashi H, Bulut H, Kiso M, Imai M, Ogata-Aoki H, Ishii T, Kobayakawa T, Nakano K, Takamune N, Kishimoto N, Hattori SI, Das D, Uemura Y, Shimizu Y, Aoki M, Hasegawa K, Suzuki S, Nishiyama A, Saruwatari J, Shimizu Y, Sukenaga Y, Takamatsu Y, Tsuchiya K, Maeda K, Yoshimura K, Iida S, Ozono S, Suzuki T, Okamura T, Misumi S, Kawaoka Y, Tamamura H, Mitsuya H. Identification of SARS-CoV-2 M(pro) inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nature communications. 2023.02; 14 (1): 1076. ( PubMed, DOI )
-
Tsuji K, Kobayakawa T, Ishii T, Higashi-Kuwata N, Azuma C, Shinohara K, Miura Y, Yamamoto K, Nishimura S, Hattori SI, Bulut H, Mitsuya H, Tamamura H. Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement. Chemical & pharmaceutical bulletin. 2023; 71 (12): 879-886. ( PubMed, DOI )
-
Matsuura K, Yamaura M, Sakawaki H, Himeno A, Pisil Y, Kobayakawa T, Tsuji K, Tamamura H, Matsushita S, Miura T. Sensitivity to a CD4 mimic of a consensus clone of monkey-adapted CCR5-tropic SHIV-MK38C. Virology. 2022.12; 578 171-179. ( PubMed, DOI )
-
Kitamura H, Sukegawa S, Matsuda K, Tanimoto K, Kobayakawa T, Takahashi K, Tamamura H, Tsuchiya K, Gatanaga H, Maeda K, Takeuchi H. 4-phenylquinoline-8-amine induces HIV-1 reactivation and apoptosis in latently HIV-1 infected cells. Biochemical and biophysical research communications. 2022.12; 641 139-147. ( PubMed, DOI )
-
Matsumoto K, Kuwata T, Tolbert WD, Richard J, Ding S, Prévost J, Takahama S, Judicate GP, Ueno T, Nakata H, Kobayakawa T, Tsuji K, Tamamura H, Smith AB 3rd, Pazgier M, Finzi A, Matsushita S. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates. Journal of virology. 2022.12; 97 (1): e0163822. ( PubMed, DOI )
-
Tsuji K, Ishii T, Kobayakawa T, Higashi-Kuwata N, Azuma C, Nakayama M, Onishi T, Nakano H, Wada N, Hori M, Shinohara K, Miura Y, Kawada T, Hayashi H, Hattori SI, Bulut H, Das D, Takamune N, Kishimoto N, Saruwatari J, Okamura T, Nakano K, Misumi S, Mitsuya H, Tamamura H. Potent and biostable inhibitors of the main protease of SARS-CoV-2. iScience. 2022.11; 105365. ( PubMed, DOI )
-
Tsuji K, Ishii T, Kobayakawa T, Higashi-Kuwata N, Azuma C, Nakayama M, Onishi T, Nakano H, Wada N, Hori M, Shinohara K, Miura Y, Kawada T, Hayashi H, Hattori SI, Bulut H, Das D, Takamune N, Kishimoto N, Saruwatari J, Okamura T, Nakano K, Misumi S, Mitsuya H, Tamamura H. Potent and biostable inhibitors of the main protease of SARS-CoV-2. iScience. 2022.11; 105365. ( PubMed, DOI )
-
Tsuji K, Kobayakawa T, Konno K, Masuda A, Takahashi K, Ohashi N, Yoshimura K, Kuwata T, Matsushita S, Harada S, Tamamura H. Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors. Bioorganic & medicinal chemistry. 2022.01; 56 116616. ( PubMed, DOI )
-
Tsuji Kohei, Ishii Takahiro, Kobayakawa Takuya, Ohashi Nami, Nomura Wataru, Tamamura Hirokazu. Fluorescence resonance energy transfer-based screening for protein kinase C ligands using 6-methoxynaphthalene-labeled 1,2-diacylglycerol-lactones ORGANIC & BIOMOLECULAR CHEMISTRY. 2021.07; 19 (38): 8264-8271. ( PubMed, DOI )
-
Kobayakawa T, Azuma C, Watanabe Y, Sawamura S, Taniguchi A, Hayashi Y, Tsuji K, Tamamura H. Development of Methods for Convergent Synthesis of Chloroalkene Dipeptide Isosteres and Its Application. The Journal of organic chemistry. 2021.04; 86 (7): 5091-5101. ( PubMed, DOI )
-
Kobayakawa T, Yokoyama M, Tsuji K, Fujino M, Kurakami M, Boku S, Nakayama M, Kaneko M, Ohashi N, Kotani O, Murakami T, Sato H, Tamamura H. Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins. Biomolecules. 2021.02; 11 (2): ( PubMed, DOI )
-
Kobayakawa T, Tsuji K, Konno K, Himeno A, Masuda A, Yang T, Takahashi K, Ishida Y, Ohashi N, Kuwata T, Matsumoto K, Yoshimura K, Sakawaki H, Miura T, Harada S, Matsushita S, Tamamura H. Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry Inhibitors. Journal of medicinal chemistry. 2021.01; ( PubMed, DOI )
-
Kouki Matsuda, Takuya Kobayakawa, Ryusho Kariya, Kiyoto Tsuchiya, Kohei Tsuji, Takahiro Ishii, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Seiji Okada, Hiroaki Mitsuya, Hirokazu Tamamura & Kenji Maeda. A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators. Frontiers in Microbiology. 2021; 12 636276. ( PubMed, DOI )
-
Takuya Kobayakawa, Hirokazu Tamamura. Chloroalkene dipeptide isosteres as peptidomimetics. Methods in enzymology. 2021; 656 191-239. ( PubMed, DOI )
-
Kobayakawa Takuya, Ebihara Kento, Tsuji Kohei, Kawada Takuma, Fujino Masayuki, Honda Yuzuna, Ohashi Nami, Murakami Tsutomu, Tamamura Hirokazu. Bivalent HIV-1 fusion inhibitors based on peptidomimetics BIOORGANIC & MEDICINAL CHEMISTRY. 2020.12; 28 (24): 115812. ( PubMed, DOI )
-
Tsuji K, Wang R, Kobayakawa T, Owusu KB, Fujino M, Kaneko M, Yamamoto N, Murakami T, Tamamura H. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment. Bioorganic & medicinal chemistry. 2020.12; 30 115923. ( PubMed, DOI )
-
Kohei Tsuji, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Rongyi Wang, Masayuki Fujino, Moemi Kaneko, Naoki Yamamoto, Tsutomu Murakami, Hirokazu Tamamura. Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment. Bioorg. Med. Chem. 2020.06; 28 (11): 115488. ( PubMed, DOI )
-
Takuya Kobayakawa, Hikaru Takano, Takahiro Ishii, Kohei Tsuji, Nami Ohashi, Wataru Nomura, Toshiaki Furuta, Hirokazu Tamamura. Synthesis of hydrophilic caged DAG-lactones for chemical biology applications. Org. Biomol. Chem. 2020.05; 18 (22): 4217-4223 . ( PubMed, DOI )
-
Maeda Kenji, Matsuda Kouki, Islam Saiful, Kobayakawa Takuya, Tsuchiya Kiyoto, Hattori Shin-ichiro, Gatanaga Hiroyuki, Oka Shinichi, Yoshimura Kazuhisa, Tamamura Hirokazu, Mitsuya Hiroaki, Satou Yorifumi. HIV持続潜伏感染に関する最先端研究(Treatment of HIV-1-reservoirs using latency-reversing agents(LRAs) toward HIV cure) 日本エイズ学会誌. 2019.11; 21 (4): 314. ( ichushi )
-
Takuya Kobayakawa, Kento Ebihara, Yuzuna Honda, Masayuki Fujino, Wataru Nomura, Naoki Yamamoto, Tsutomu Murakami, Hirokazu Tamamura. Dimeric C34 Derivatives Linked through Disulfide Bridges as New HIV-1 Fusion Inhibitors. Chembiochem. 2019.08; 20 (16): 2101-2108. ( PubMed, DOI )
-
Kenji Maeda, Debananda Das, Takuya Kobayakawa, Hirokazu Tamamura, Hiroaki Takeuchi. Discovery and Development of anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication. Current topics in medicinal chemistry. 2019.07; 19 (18): 1621-1649. ( PubMed, DOI )
-
Maxwell M Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a NanoBRET-Based Sensitive Screening Method for CXCR4 Ligands. Bioconjug. Chem.. 2019.05; 30 (5): 1442-1450. ( PubMed, DOI )
-
Maxwell M. Sakyiamah, Takuya Kobayakawa, Masayuki Fujino, Makoto Konno, Tetsuo Narumi, Tomohiro Tanaka, Wataru Nomura, Naoki Yamamoto, Tsutomu Murakami, Hirokazu Tamamura. Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands BIOORGANIC & MEDICINAL CHEMISTRY. 2019.03; 27 (6): 1130-1138. ( PubMed, DOI )
-
Takuya Kobayakawa, Kiju Konno, Nami Ohashi, Kohei Takahashi, Ami Masuda, Kazuhisa Yoshimura, Shigeyoshi Harada, Hirokazu Tamamura. Soluble-type small-molecule CD4 mimics as HIV entry inhibitors. Bioorg. Med. Chem. Lett.. 2019.03; 29 (5): 719-723. ( PubMed, DOI )
-
Kouki Matsuda, Takuya Kobayakawa, Kiyoto Tsuchiya, Shin-Ichiro Hattori, Wataru Nomura, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shinichi Oka, Yasuyuki Endo, Hirokazu Tamamura, Hiroaki Mitsuya, Kenji Maeda. Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal. J. Biol. Chem.. 2019.01; 294 (1): 116-129. ( PubMed, DOI )
-
Wataru Nomura, Daisuke Matsumoto, Taisuke Sugii, Takuya Kobayakawa, Hirokazu Tamamura. Efficient and Orthogonal Transcription Regulation by Chemically Inducible Artificial Transcription Factors. Biochemistry. 2018.11; 57 (45): 6452-6459. ( PubMed, DOI )
-
Takuya Kobayakawa, Nami Ohashi, Yuki Hirota, Kohei Takahashi, Yuko Yamada, Tetsuo Narumi, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Flexibility of small molecular CD4 mimics as HIV entry inhibitors. Bioorg. Med. Chem.. 2018.11; 26 (21): 5664-5671. ( PubMed, DOI )
-
Kei Toyama, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Delivery of a Proapoptotic Peptide to EGFR-Positive Cancer Cells by a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR. Bioconjug. Chem.. 2018.06; 29 (6): 2050-2057. ( PubMed, DOI )
-
Wataru Nomura, Daisuke Matsumoto, Taisuke Sugii, Takuya Kobayakawa. Chemically-controlled orthogonal regulation of multiple endogenous genes FASEB Journal. 2018.04; 32 (1):
-
Takuya Kobayakawa, Yudai Matsuzaki, Kentaro Hozumi, Wataru Nomura, Motoyoshi Nomizu, Hirokazu Tamamura. Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application. ACS Medicinal Chemistry Letters. 2018.01; 9 (1): 6-10. ( PubMed, DOI )
-
Kei Toyama, Takuya Kobayakawa, Wataru Nomura, Hirokazu Tamamura. Inhibition of EGFR Activation by Bivalent Ligands Based on a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR. Chem. Pharm. Bull.. 2018; 66 (11): 1083-1089. ( PubMed, DOI )
-
Takuya Kobayakawa, Hirokazu Tamamura. Stereoselective synthesis of Xaa-Yaa type (Z)-chloroalkene dipeptide isosteres via efficient utilization of organocopper reagents mediated allylic alkylation Tetrahedron. 2017.07; 73 (30): 4464-4471. ( DOI )
-
Takuya Kobayakawa. Synthetic Studies on Chloroalkene Dipeptide Isosteres as Peptidomimetics 国立大学法人 東京医科歯科大学. 2017.03;
-
Takuya Kobayakawa, Hirokazu Tamamura. Efficient synthesis of Xaa-Gly type (Z)-chloroalkene dipeptide isosteres via organocuprate mediated reduction Tetrahedron. 2016.08; 72 (32): 4968-4971. ( DOI )
-
Kobayakawa Takuya, Tamamura Hirokazu. Development of synthetic methodology of chloroalkene-type dipeptide isosteres for peptidomimetics ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2016.08; 252
-
Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Stereoselective Synthesis of Chloroalkene Dipeptide Isosteres Utilizing Organocopper Reagents PEPTIDE SCIENCE 2015. 2016.03; 97-98.
-
Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Remote Stereoinduction in the Organocuprate-Mediated Allylic Alkylation of Allylic gem-Dichlorides: Highly Diastereoselective Synthesis of (Z)-Chloroalkene Dipeptide Isosteres. Organic Letters. 2015.05; 17 (10): 2302-2305. ( PubMed, DOI )
-
Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Development of Efficient Synthetic Methodologies of Chloroalkene Dipeptide Isosteres PEPTIDE SCIENCE 2014. 2015.03; 13-14.
-
Tetsuo Narumi, Haruo Aikawa, Tomohiro Tanaka, Chie Hashimoto, Nami Ohashi, Wataru Nomura, Takuya Kobayakawa, Hikaru Takano, Yuki Hirota, Tsutomu Murakami, Naoki Yamamoto, Hirokazu Tamamura. Low-molecular-weight CXCR4 ligands with variable spacers. ChemMedChem. 2013.01; 8 (1): 118-124. ( PubMed, DOI )
-
Tetsuo Narumi, Takuya Kobayakawa, Haruo Aikawa, Shunsuke Seike, Hirokazu Tamamura. Stereoselective formation of trisubstituted (Z)-chloroalkenes adjacent to a tertiary carbon stereogenic center by organocuprate-mediated reduction/alkylation. Organic Letters. 2012.09; 14 (17): 4490-4493. ( PubMed, DOI )
Books etc 【 display / non-display 】
-
Hirokazu Tamamura, Takuya Kobayakawa, Nami Ohashi. Mid-size Drugs Based on Peptides and Peptidomimetics. Springer Singapore, 2018.01 (ISBN : 978-981-10-7691-6)
-
Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Stereoselective Synthesis of Chloroalkene Dipeptide Isosteres Utilizing Organocopper Reagents. The Japanese Peptide Society, 2016.03
-
Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Development of Efficient Synthetic Methodologies of Chloroalkene Dipeptide Isosteres. in "Peptide Science 2014," ed. by Akira Otaka, The Japanese Peptide Society, Osaka. The Japanese Peptide Society, 2015.03
Conference Activities & Talks 【 display / non-display 】
-
山本 賢一、小早川 拓也、東 知佳、渡邉 優基、辻 耕平、玉村 啓和. アミロイドbeta凝集阻害剤を指向したクロロアルケン型ペプチドミメティックの創製. 日本薬学会第144回年会 2024.03.31 横浜
-
黒田 悠貴, 小早川 拓也, 辻 耕平, 紺野 奇重, 大橋 南美, 増田 亜美, 三浦 裕太郎, 桑田 岳夫, 吉村 和久, 三浦 智行, 原田 恵嘉, 松下 修三, 玉村 啓和. HIV侵入阻害剤としてのポリエチレングリコールと低分子CD4ミミックのハイブリッド化合物の創製. 日本薬学会第144回年会 2024.03.30 横浜
-
町田 沙穂, 小早川 拓也, 横山 勝, 藤野 真之, 金子 萌美, 倉上 真樹, 朴 清香, 大西 立人, 小谷 治, 辻 耕平, 村上 努, 佐藤 裕徳, 玉村 啓和. HIV-1カプシドタンパク質の構造を起点とした低分子型抗HIV-1剤の創製. 日本薬学会第144回年会 2024.03.30 横浜
-
西村 壮史, 小早川 拓也, 辻 耕平, 村上 努, 玉村 啓和. HIV-1外被タンパク質gp41を標的とする二価型膜融合阻害剤の創製. 日本薬学会第144回年会 2024.03.30 横浜
-
篠原 功紀,鍬田 伸好,辻 耕平,石井 貴大,小早川 拓也,服部 真一朗,岸本 直樹,高宗 暢暁,三隅 将吾,Haydar Bulut,林 宏典,満屋 裕明,玉村 啓和. SARS-CoV-2メインプロテアーゼを標的とした高抗ウイルス活性を有する低分子阻害剤の創製. 日本薬学会第144回年会 2024.03.30 横浜
-
Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of synthetic strategies for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 15th International Kyoto Conference on New Aspects of Organic Chemistry 2023.11.21 Kyoto
-
Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of convergent synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 60th Japanese Peptide Symposium 2023.11.08 Otsu
-
Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Chika Azuma, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of novel SARS-CoV-2 main protease inhibitors with potent antiviral activity. The 60th Japanese Peptide Symposium 2023.11.08 Otsu
-
Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Combinational use of CD4 mimic with other anti-HIV agents and development of these hybrid molecules. 14th International Peptide Symposium 2023.10.17 Brisbane
-
Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Double target inhibitors of HIV-1 entry based on hybrid molecules of CD4 mimics and HIV-1 gp41-related peptides. 26th Korean Peptide Protein Symposium 2023.07.04 Jeju
-
Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura . Design and Synthesis of SARS-CoV-2 Mpro Inhibitors Containing Flurine Atoms and Amide Surrogates. 26th KPPS Annual Symposium 2023.07.03 Jeju
-
Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Nami Ohashi, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura . Structure-Activity Relationship Studies of DAG-lactone Derivatives with HIV-1 Latancy Reversing Activity. 14th AFMC International Medicinal Chemistry Symposium 2023.06.27 Seoul
-
Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Hybrid molecules of CD4 mimic and HIV-1 fusion inhibitors. 14th AFMC International Medicinal Chemistry Symposium 2023.06.26 Seoul
-
Kohei Tsuji, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Youichi Suzuki, Hirokazu Tamamura. Development of fusion inhibitor peptides of SARS-CoV-2 learned from anti-HIV-1 agents. 第59回ペプチド討論会 2022.10.26 仙台
-
Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of SARS-CoV-2 main protease inhibitors. 第59回ペプチド討論会 2022.10.26 仙台
-
Yutaro Miura, Takuya Kobayakawa, Kohei Tsuji, Kiju Konno, Ami Masuda, Nami Ohashi, Takeo Kuwata, Kazuhisa Yoshimura, Tomoyuki Miura, Shigeyoshi Harada, Shuzo Matsushita, Hirokazu Tamamura. Pegylated CD4 mimics as HIV inhibitors. 第59回ペプチド討論会 2022.10.26 仙台
-
Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Synthesis of inhibitors targeting the main protease of SARS-CoV-2 for therapeutics of COVID-19. 第59回ペプチド討論会 2022.10.26 仙台
-
Kohei Tsuji, Rongyi Wang, Kofi Owusu B.-A., Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Exploration of novel class anti-HIV-1 agents derived from a viral capsid protein. 36th European and 12th International Peptide Symposium 2022.08.29 Spain
-
石井 貴大, 小早川 拓也, 松田 幸樹, 辻 耕平, 吉村 和久, 満屋 裕明, 前田 賢次, 玉村 啓和. HIV 感染症の根治を指向した DAG-ラクトン誘導体の構造最適化研究. 日本ケミカルバイオロジー学会 第16回年会 2022.05.31 富山
-
石井 貴大, 小早川 拓也, 松田 幸樹, 辻 耕平, 吉村 和久, 満屋 裕明, 前田 賢次, 玉村 啓和. HIV感染症の根治を指向したDAG-ラクトン誘導体の合成. 日本薬学会第142年会 2022.03.27 online
-
Hirokazu Tamamura, Takuya Kobayakawa, Kento Ebihara, Tsutomu Murakami, Kohei Tsuji. Development of HIV-1 fusion inhibitors based on dimeric derivatives of the C34 peptide and its peptidomimetics. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.18 online (Hawaii)
-
Kohei Tsuji, Rongyi Wang, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Explorative study in development of anti-HIV-1 peptides based on HIV-1 capsid protein segments. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.15 online (Hawaii)
-
Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura. Development of protein kinase C activators for cure of HIV infectious diseases. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.15 online (Hawaii)
-
Takuya Kobayakawa, Kohei Tsuji, Kiju Konno, Ami Masuda, Nami Ohashi, Takeo Kuwata,Kazuhisa Yoshimura, Tomoyuki Miura, Shigeyoshi Harada, Shuzo Matsushita, Hirokazu Tamamura. HIV entry inhibitors based on CD4 mimics with PEG units toward cure for HIV-infectious diseases. The 13th AFMC International Medicinal Chemistry Symposium 2021.12.02 online (Tokyo)
-
Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura. Structure-Activity Relationship Studies of Protein Kinase C Activators Derived from Diacylglycerol for Cure of HIV Infectious Diseases. The 13th AFMC International Medicinal Chemistry Symposium 2021.11.29 online (Tokyo)
-
Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. HYBRID MOLECULES OF CD4 MIMIC AND HIV-1 GP41-RELATED PEPTIDES AS FUSION INHIBITORS. 第58回ペプチド討論会 2021.10.22 online(Tokyo)
-
Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nami Ohashi, Wataru Nomura, Hirokazu Tamamura. A FRET-BASED ASSAY SYSTEM FOR PROTEIN KINASE C LIGAND SCREENING USING 1,2-DIACYLGLYCEROL-LACTONE DERIVATIVE. 第58回ペプチド討論会 2021.10.20 online(Tokyo)
-
Wataru Nomura, Takumi Kamimura, Takuya Kobayakawa, Hirokazu Tamamura. Endogenous protein expression imaging by fluorogenic ZIP tag-probe system. 第57回ペプチド討論会 2020.11.10 online
-
Kofi Baffour-Awuah Owusu, Kohei Tsuji, Rongyi Wang, Takuya Kobayakawa, Moemi Kaneko, Tsutomu Murakami, Hirokazu Tamamura. Exploratory studies on the development of anti-HIV-1 peptides based on HIV-1 capsid fragments. 第57回ペプチド討論会 2020.11.10 online
-
Chika Azuma, Takuya Kobayakawa, Kohei Tsuji, Hirokazu Tamamura. A convergent synthesis of chloroalkene dipeptide isosteres as peptidomimetics. 第57回ペプチド討論会 2020.11.09 online
-
Maeda Kenji, Matsuda Kouki, Islam Saiful, Kobayakawa Takuya, Tsuchiya Kiyoto, Hattori Shin-ichiro, Gatanaga Hiroyuki, Oka Shinichi, Yoshimura Kazuhisa, Tamamura Hirokazu, Mitsuya Hiroaki, Satou Yorifumi. HIV持続潜伏感染に関する最先端研究 HIV治癒に向けたlatency reversing agents(LRAs)を用いたHIV-1リザーバーの治療(Treatment of HIV-1-reservoirs using latency-reversing agents(LRAs) toward HIV cure). 日本エイズ学会誌 2019.11.01
-
Maeda Kenji, Matsuda Kouki, Islam Saiful, Kobayakawa Takuya, Tsuchiya Kiyoto, Hattori Shin-ichiro, Gatanaga Hiroyuki, Oka Shinichi, Yoshimura Kazuhisa, Tamamura Hirokazu, Mitsuya Hiroaki, Satou Yorifumi. HIV持続潜伏感染に関する最先端研究 HIV治癒に向けたlatency reversing agents(LRAs)を用いたHIV-1リザーバーの治療(Treatment of HIV-1-reservoirs using latency-reversing agents(LRAs) toward HIV cure). 日本エイズ学会誌 2019.11.01
-
Maeda Kenji, Matsuda Kouki, Islam Saiful, Kobayakawa Takuya, Tsuchiya Kiyoto, Hattori Shin-ichiro, Gatanaga Hiroyuki, Oka Shinichi, Yoshimura Kazuhisa, Tamamura Hirokazu, Mitsuya Hiroaki, Satou Yorifumi. HIV持続潜伏感染に関する最先端研究 HIV治癒に向けたlatency reversing agents(LRAs)を用いたHIV-1リザーバーの治療(Treatment of HIV-1-reservoirs using latency-reversing agents(LRAs) toward HIV cure). 日本エイズ学会誌 2019.11.01
-
Maeda Kenji, Matsuda Kouki, Islam Saiful, Kobayakawa Takuya, Tsuchiya Kiyoto, Hattori Shin-ichiro, Gatanaga Hiroyuki, Oka Shinichi, Yoshimura Kazuhisa, Tamamura Hirokazu, Mitsuya Hiroaki, Satou Yorifumi. HIV持続潜伏感染に関する最先端研究 HIV治癒に向けたlatency reversing agents(LRAs)を用いたHIV-1リザーバーの治療(Treatment of HIV-1-reservoirs using latency-reversing agents(LRAs) toward HIV cure). 日本エイズ学会誌 2019.11.01
-
Maeda Kenji, Matsuda Kouki, Islam Saiful, Kobayakawa Takuya, Tsuchiya Kiyoto, Hattori Shin-ichiro, Gatanaga Hiroyuki, Oka Shinichi, Yoshimura Kazuhisa, Tamamura Hirokazu, Mitsuya Hiroaki, Satou Yorifumi. HIV持続潜伏感染に関する最先端研究 HIV治癒に向けたlatency reversing agents(LRAs)を用いたHIV-1リザーバーの治療(Treatment of HIV-1-reservoirs using latency-reversing agents(LRAs) toward HIV cure). 日本エイズ学会誌 2019.11.01
-
Tsutomu Murakami, Kento Ebihara, Takuya Kobayakawa, Masayuki Fujino, Eiichi Kodama, Hirokazu Tamamura. Elucidation of mechanism of HIV-1 fusion inhibitors developed by dimerization strategy. The 67th Annual Meeting of the Japanese Society for Virology 2019.10.29 Tokyo
-
Kouki Matsuda, Takuya Kobayakawa, Kiyoto Tsuchiya, Shin-ichiro Hattori, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shinichi Oka, Yasuyuki Endo, Hirokazu Tamamura, Hiroaki Mitsuya, Kenji Maeda. Benzolactam protein kinase C activators promote apoptosis of HIV-infected human cells via HIV latency reversal. The 67th Annual Meeting of the Japanese Society for Virology 2019.10.29 Tokyo
-
Wataru Nomura, Takumi Kamimura, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic ZIP tag-probe system for fluorescent imaging of endogenous protein expression. The 56th Japanese Peptide Symposium 2019.10.25 Tokyo
-
Rongyi Wang, Takuya Kobayakawa, Moemi Kaneko, Kofi Owusu, Tsutomu Murakami, Hirokazu Tamamura. Development of cell-permeable anti-HIV peptides based on capsid proteins. The 56th Japanese Peptide Symposium 2019.10.25 Tokyo
-
Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a nanoBRET-based sensitive screening method to search for chemokine receptor CXCR4 ligands. The 56th Japanese Peptide Symposium 2019.10.25 Tokyo
-
Yuki Watanabe, Takuya Kobayakawa, Atsuhiko Taniguchi, Yoshio Hayashi, Hirokazu Tamamura. Development of peptidomimetic inhibitors for aggregation of amyloid beta. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo
-
Takuya Kobayakawa, Hirokazu Tamamura. Development of chemical synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo
-
Masaki Kurakami, Takuya Kobayakawa, Masaru Yokoyama, Tsutomu Murakami, Moemi Kaneko, Osamu Kotani, Hironori Sato, Hirokazu Tamamura. Structure-activity relationship studies of small molecular anti-HIV-1 compounds targeting a dipeptide site of HIV-1 capsid proteins. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo
-
Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Development of HIV-1 fusion inhibitors based on the C34 dimer derived from an HIV-1 envelope protein gp41. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo
-
Wataru Nomura , Takumi Kamimura, Daisuke Matsumoto, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic and genetically encodable tag-probe system for in-cell imaging of protein synthesis . 10th International Peptide Symposium 2018.12.05 Kyoto, Japan
-
Takuya Kobayakawa, Hirokazu Tamamura. Synthetic Strategy of Peptidomimetic Based on Chloroalkene Dipeptide Isoteres and Its Biological Application. 10th International Peptide Symposium 2018.12.03 Kyoto, Japan
-
Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. HIV-1 Fusion Inhibitors Based on gp41-C34 dimers. 10th International Peptide Symposium 2018.12.03 Kyoto, Japan
-
Takuya Kobayakawa, Kohei Takahashi, Ami Masuda, Shigeyoshi Harada, Tomoyuki Miura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Structure‐activity relationship studies of CD4 mimic molecules for targeting an envelope protein gp120 on HIV-1. 19th Kumamoto AIDS Seminar 2018.11.06 Kumamoto, Japan
-
Takuya Kobayakawa, Kohei Takahashi, Ami Masuda, Shigeyoshi Harada, Tomoyuki Miura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Structure‐activity relationship studies of CD4 mimic molecules for targeting an envelope protein gp120 on HIV-1. 19th Kumamoto AIDS Seminar 2018.11.06 Kumamoto, Japan
-
Tsutomu Murakami, Kento Ebihara, Masayuki Fujino, Yuzuna Honda, Takuya Kobayakawa, Wataru Nomura, Hirokazu Tamamura. Development of new membrane fusion inhibitors against HIV-1 by “dimerization” strategy. The 66th Annual Meeting of the Japanese Society for Virology 2018.10.28 Kyoto, Japan
-
Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a new NanoBRET assay system for CXCR4 ligands and their Structure-activity relationship studies. Frontiers 2018 Symposium (EPFL/TMDU/UTokyo Joint Symposium) 2018.09.21 Lausanne, Switzerland
-
Maxwell Mamfe Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of NanoBRET assay system in living cells for structure-activity relationship studies of CXCR4 ligands. The 62nd Annual Meeting of the Pharmaceutical Society of Japan Kanto Branch 2018.09.15 Tokyo, Japan
-
小早川 拓也. “化学”から“薬”の開発へ. 2018年度 国立大学法人 東京医科歯科大学 オープンキャンパス サイエンスカフェ(最新医歯学研究)~研究者の話を聞こう~ 2018.07.27 東京, 日本
-
Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of NanoBRET assay system in living cells to search potent CXCR4 ligands. The 13th Annual Meeting of Japanese Society for Chemical Biology 2018.06.13 Tokyo, Japan
-
Tsutomu Murakami, Masayuki Fujino, Masaru Yokoyama, Takuya Kobayakawa, Hiroaki Takeuchi, Takao Masuda, Osamu Kotani, Hirokazu Tamamura, Hironori Sato. Biological and molecular characterization of a novel anti-HIV-1 compound created by in silico design and de novo organic synthesis. Cold Spring Harbor Laboratory Meetings & Courses, Retrovirus Meeting 2018.05.23 Cold Spring Harbor, United States of America
-
Maxwell M. Sakyiamah, Wataru Nomura, Hirokazu Tamamura. Development of a sensitive screening method to search potent ligands of CXCR4. 138th Annual Meeting of the Pharmaceutical Society of Japan 2018.03.26 Ishikawa, Japan
-
Wataru Nomura, Daisuke Matsumoto, Taisuke Sugii, Takuya Kobayakawa, Hirokazu Tamamura. Differential regulation of endogenous genes in an orthogonal manner by distinct chemically inducible systems. International Conference on Epigenetics and Bioengineering 2017.12.13 Miami, United States of America
-
Kouki Matsuda, Shin-ichiro Hattori, Kiyoto Tsuchiya, Takuya Kobayakawa, Ohashi Nami, Wataru Nomura, Shigeyoshi Harada, Yorifumi Sato, Kazuhisa Yoshimura, Hirokazu Tamamura, Hiroaki Mitsuya, Kenji Maeda. Development of novel therapeutics to eliminate latently infected cells by LRAs toward HIV cure. 18th KUMAMOTO AIDS Seminar 2017.10.31 Kumamoto, Japan
-
Ami Masuda, Shigeyoshi Harada, Shokichi Takahama, Kohei Takahashi, Kiju Konno, Takuya Kobayakawa, Ai Himeno, Tomoyuki Miura, Takeo Kuwata, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Development of CD4 mimics for enhancement of activity of HIV neutralizing antibodies. 18th KUMAMOTO AIDS Seminar 2017.10.31 Kumamoto, Japan
-
Nami Ohashi, Shigeyoshi Harada, Yu Irahara, Yusuke Ishida, Kiju Konno, Takuya Kobayakawa, Wataru Nomura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. CD4 Mimics for Enhancement of Activity of HIV Neutralizing Antibodies. The 11th AFMC International Medicinal Chemistry Symposium 2017.07.24 Melbourne, Australia
-
Takuya Kobayakawa, Hirokazu Tamamura. Development of Synthetic Methods for Chloroalkene Dipeptide Isosteres and Their Applications. The 25th American Peptide Symposium and the 9th International Peptide Symposium 2017.06.19 Whistler, Canada
-
Takuya Kobayakawa, Yudai Matsuzaki, Wataru Nomura, Kentaro Hozumi, Motoyoshi Nomizu, Hirokazu Tamamura. Development of Chloroalkene Dipeptide Isosteres as Peptidomimetics and Their Application. The 2nd Peptides and Proteins Society of Singapore Symposium 2016.12.08 Nanyang Technological University, Singapore
-
Takuya Kobayakawa, Hirokazu Tamamura. Development of synthetic methodology of chloroalkene-type dipeptide isosteres for peptidomimetics. 252nd American Chemical Society National Meeting 2016.08.23 Pennsylvania, United States of America
-
Tetsuo Narumi, Takuya Kobayakawa, Hirokazu Tamamura. Highly Diastereoselective Synthesis of (Z)-Chloroalkene Dipeptide Isosteres by Remote Stereoinduction in the Organocuprate-Mediated Allylic Alkylation of Allylic gem-Dichlorides. Molecular Chirality Asia 2016 2016.04.20 Osaka, Japan
-
Takuya Kobayakawa, Hirokazu Tamamura. Development of Chloroalkene Dipeptide Isosteres as Peptidomimetic Based on the Ground State of Peptide Bonds. 第8回武田科学振興財団薬科学シンポジウム 生命分子から薬を創る -中分子薬を中心に- 2016.01.26 大阪, 日本
-
Takuya Kobayakawa, Hirokazu Tamamura. Development of Synthetic Methods for Chloroalkene Dipeptide Isosteres as Peptidomimetic Based on the Ground State of Amide Bonds. The 7th International Peptide Symposium 2015.12.09 Matrix Biopolis, Singapore
-
小早川 拓也. 多種のクロロアルケン型ジペプチドイソスターの合成法の開発. 13th IBB BioFuture Research Encouragement Prize研究発表会 2015.01.30 東京, 日本
-
Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Development of Efficient Synthetic Methodologies of Chloroalkene Dipeptide Isosteres. 第51回ペプチド討論会 2014.10.22 徳島, 日本
-
Tetsuo Narumi, Takuya Kobayakawa, Hirokazu Tamamura. Design and Synthesis of Chloroalkene Dipeptide Isosteres as Ground State Peptidomimetics. The 10th Australian Peptide Conference 2013.09.08 Penang, Malaysia
Patents 【 display / non-display 】
-
CD4 MIMIC COMPOUND WITH ANTI-HIV ACTIVITY
Patent Number: 特許第7297220号
Others 【 display / non-display 】
-
A new, promising weapon in the fight against HIV,2023.06
-
Expanding the arsenal of drugs against COVID-19,2022.12
-
HIV has been had,2021.04
Campus class subject 【 display / non-display 】
-
Practical Chemical Biology,2018 - Now
-
Development of Functional Molecules,2018 - Now
-
Introduction to Chemistry and Biology of Biofunctional Molecules,2018 - Now
External class subject 【 display / non-display 】
-
,Tokyo Kasei University
-
,Tokyo Kasei University
Performance of duties 【 display / non-display 】
-
,2023.09
-
,2023.01
-
,2022.02
-
,2021.05
-
,2021.01
-
,2020.01
-
,2019.01
-
,2019.01
-
,2019.01
-
,2018.08
-
,2018.06
-
,2018.04 - 2021.03
-
,2018.04 - 2020.03
-
,2018.04 - 2020.03
-
,2018.04 - 2019.03
-
,2018.03
-
,2018.02
-
,2018.02
-
,2017.06
-
,2017.01
-
,2017.01
-
,2016.07
-
,2016.07
-
,2016.06
-
,2016.01
-
,2015.07
-
,2013.07
-
,2013.06
-
,2012.04 - Now
Social Contribution 【 display / non-display 】
-
Frontier Research on Medicinal Chemistry of Mid-sized Molecules,Kanazawa, Japan,2018.03.28